ClinicalTrials.Veeva

Menu
N

Northwest Clinical Trials | Boise, US

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Galcanezumab
LY900014
Rimegepant
Troriluzole
Itraconazole
Bococizumab
Donanemab
Testosterone Undecanoate
Atogepant
Canakinumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 58 total trials

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD) over up...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling
Major Depressive Disorder
Drug: Placebo
Drug: Azetukalner

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participant...

Active, not recruiting
Chronic Migraine
Drug: Placebo
Drug: Galcanezumab

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatme...

Active, not recruiting
Episodic Migraine
Drug: Galcanezumab
Drug: Placebo

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: Remternetug
Locations recently updated

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and ado...

Enrolling
Migraine
Drug: Placebo
Drug: Rimegepant

This Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick...

Enrolling
Actinic Keratosis
Drug: Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%
Device: Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170E.

Trial sponsors

Lilly logo
Pfizer logo
AbbVie logo
A
Allergan logo
AstraZeneca logo
Biohaven logo
M
Novartis logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems